SCHEMBL402022

SCHEMBL402022

COC(=O)c1ccc(-c2nc(C)ccc2C(=O)Nc2ccc(CCCC(=O)Oc3c(C)cc(C(=O)OC)cc3Cl)cc2C(=O)N(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.36
PRSS12 P56730 2/20 0.32
F10 P00742 2/20 0.32
NTRK1 P04629 1/20 0.31
NTRK2 Q16620 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
PTGES O14684 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 2/20 0.30
RAB9A P51151 1/20 0.30
TAS1R3 Q7RTX0 1/20 0.30
TAS1R1 Q7RTX1 1/20 0.30
TAS1R2 Q8TE23 1/20 0.30
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
CTSA P10619 1/20 0.30
DRD2 P14416 1/20 0.30
TBXA2R P21731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319572 0.97 KCNH2 (0.35) KCNH2PRSS12F10NTRK1NTRK2
SCHEMBL401988 0.93 NTRK1 (0.39) KCNH2PRSS12F10NTRK1NTRK2
SCHEMBL403307 0.93 KCNH2 (0.36) KCNH2PRSS12F10MEN1KMT2A
SCHEMBL403406 0.93 KCNH2 (0.34) KCNH2PRSS12NTRK1NTRK2MEN1
Hydrochloric Acid SCHEMBL401987 0.93 NTRK1 (0.39) KCNH2PRSS12F10NTRK1NTRK2
SCHEMBL402646 0.91 NTRK1 (0.38) KCNH2NTRK1NTRK2
SCHEMBL402904 0.90 KCNH2 (0.36) KCNH2PRSS12F10NTRK1NTRK2
SCHEMBL403407 0.89 PRSS12 (0.34) KCNH2PRSS12NTRK1NTRK2MEN1
SCHEMBL401200 0.88 NTRK1 (0.40) KCNH2PRSS12F10NTRK1NTRK2
SCHEMBL403346 0.88 NTRK1 (0.42) KCNH2NTRK1NTRK2PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP claimed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US claimed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA KCNH2 4171/4885PRSS12 2785/4885F10 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.